Tag Archives: Recommends

CDC recommends new vaccine to help protect babies against severe respiratory syncytial virus (RSV) illness after birth

Today, CDC recommended the first respiratory syncytial virus (RSV) vaccine for pregnant people to protect their newborn from severe RSV illness. RSV is the leading cause of hospitalization for U.S. infants. This new vaccine, Pfizer’s bivalent RSVpreF vaccine (trade name Abrysvo TM), has been shown to reduce the risk of RSV hospitalization for babies by … Continue reading CDC recommends new vaccine to help protect babies against severe respiratory syncytial virus (RSV) illness after birth

CDC Recommends Updated COVID-19 Vaccine for Fall/Winter Virus Season

CDC recommends everyone 6 months and older get an updated COVID-19 vaccine to protect against the potentially serious outcomes of COVID-19 illness this fall and winter. Updated COVID-19 vaccines from Pfizer-BioNTech and Moderna will be available later this week.

CDC Recommends a Powerful New Tool to Protect Infants from Leading Cause of Hospitalization

CDC is recommending a new immunization starting this fall to help protect all infants under 8 months and some older babies at increased risk of severe illness caused by respiratory syncytial virus (RSV).

CDC Recommends the First Updated COVID-19 Booster

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendations for use of updated COVID-19 boosters from Pfizer-BioNTech for people ages 12 years and older and from Moderna for people ages 18 years and older.

CDC Recommends Moderna COVID-19 Vaccine for Children and Adolescents

Today, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation that Moderna’s COVID-19 vaccine be used as an option for children ages 6 through 17 years.

CDC Recommends Moderna Booster at 5 Months

CDC is adjusting our recommendation for when people can receive a booster shot, shortening the interval from 6 months to 5 months. Earlier this week CDC made this recommendation for recipients of a Pfizer-BioNTech primary series and, after FDA action this morning, we’re extending this recommendation to recipients of a Moderna primary series.